Literature DB >> 17383482

The role of mesenchymal stem cells in maintenance and repair of bone.

Robert Bielby1, Elena Jones, Dennis McGonagle.   

Abstract

The maintenance of stable bone mass during adult life, following rapid skeletal growth during childhood, is the result of a carefully controlled balance between the activities of bone forming (osteoblast) and bone resorbing (osteoclast) cells. Although skeletal turnover continues throughout adult life, the net effect of formation and resorption on bone mass is zero in healthy individuals. Later in life, bone mass begins to fall as resorption outpaces formation, particularly in post-menopausal women, which leads to increased fracture risk. The opposing actions of these two cell types are coupled by molecular interactions between them that are thought to be influenced by the actions of the precursor cells of the osteoblast lineage, mesenchymal stem cells (MSCs). In addition to regulating normal skeletal homeostasis, MSCs also play an important role in fracture repair. Bone fracture or injury initiates a series of cellular and molecular pathways that commence with hematoma formation and an inflammatory cascade that regulates MSCs activity leading to fracture healing and the reestablishment of skeletal integrity. Although tremendous strides have been made in increasing our understanding of bone biology, there is surprisingly little data about the role of MSCs in vivo in the maintenance of skeletal integrity or fracture repair. In recent years, the pivotal importance of anabolic therapies in the setting of osteoporosis in which bone mass is substantially increased above and beyond what is attainable with the bisphosphonate class of drugs has put MSC biology firmly on the scientific agenda. Although the biology of cultured MSCs is reasonably well understood, the biology of MSCs in vivo in both bone turnover and fracture repair remains poorly understood. The recent phenotypic characterization of in vivo MSCs and the ability to prospectively purify such cells will open up new avenues of research into a better understanding of the role of MSCs in bone turnover. The purpose of this article is to review bone and fracture biology from the perspective of recent advances in our understanding of MSCs and to highlight the major deficiencies in our current knowledge.

Entities:  

Mesh:

Year:  2007        PMID: 17383482     DOI: 10.1016/j.injury.2007.02.007

Source DB:  PubMed          Journal:  Injury        ISSN: 0020-1383            Impact factor:   2.586


  53 in total

1.  The effect of mesenchymal stem cells delivered via hydrogel-based tissue engineered periosteum on bone allograft healing.

Authors:  Michael D Hoffman; Chao Xie; Xinping Zhang; Danielle S W Benoit
Journal:  Biomaterials       Date:  2013-08-16       Impact factor: 12.479

Review 2.  Osteogenic differentiation of amniotic fluid mesenchymal stromal cells and their bone regeneration potential.

Authors:  Caterina Pipino; Assunta Pandolfi
Journal:  World J Stem Cells       Date:  2015-05-26       Impact factor: 5.326

3.  Intravenous vs intraperitoneal mesenchymal stem cells administration: what is the best route for treating experimental colitis?

Authors:  Fabiany da Costa Gonçalves; Natália Schneider; Fernanda Otesbelgue Pinto; Fabíola Schons Meyer; Fernanda Visioli; Bianca Pfaffenseller; Patrícia Luciana da Costa Lopez; Eduardo Pandolfi Passos; Elizabeth Obino Cirne-Lima; Luíse Meurer; Ana Helena Paz
Journal:  World J Gastroenterol       Date:  2014-12-28       Impact factor: 5.742

4.  Emulating native periosteum cell population and subsequent paracrine factor production to promote tissue engineered periosteum-mediated allograft healing.

Authors:  Michael D Hoffman; Danielle S W Benoit
Journal:  Biomaterials       Date:  2015-03-18       Impact factor: 12.479

5.  Application of Chinese herbal medicines to revitalize adult stem cells for tissue regeneration.

Authors:  Hing-Lok Wong; Wing-sum Siu; Wai-ting Shum; Si Gao; Ping-Chung Leung; Chun-Hay Ko
Journal:  Chin J Integr Med       Date:  2012-12-13       Impact factor: 1.978

6.  Safety reporting on implantation of autologous adipose tissue-derived stem cells with platelet-rich plasma into human articular joints.

Authors:  Jaewoo Pak; Jae-Jin Chang; Jung Hun Lee; Sang Hee Lee
Journal:  BMC Musculoskelet Disord       Date:  2013-12-01       Impact factor: 2.362

7.  Low intensity pulsed ultrasound (LIPUS) influences the multilineage differentiation of mesenchymal stem and progenitor cell lines through ROCK-Cot/Tpl2-MEK-ERK signaling pathway.

Authors:  Joji Kusuyama; Kenjiro Bandow; Mitsuo Shamoto; Kyoko Kakimoto; Tomokazu Ohnishi; Tetsuya Matsuguchi
Journal:  J Biol Chem       Date:  2014-02-18       Impact factor: 5.157

8.  Glycosaminoglycan mimetic associated to human mesenchymal stem cell-based scaffolds inhibit ectopic bone formation, but induce angiogenesis in vivo.

Authors:  Guilhem Frescaline; Thibault Bouderlique; Leyya Mansoor; Gilles Carpentier; Brigitte Baroukh; Fernando Sineriz; Marina Trouillas; Jean-Louis Saffar; José Courty; Jean-Jacques Lataillade; Dulce Papy-Garcia; Patricia Albanese
Journal:  Tissue Eng Part A       Date:  2013-07       Impact factor: 3.845

9.  In vitro hypertrophy and calcification of human fracture haematoma-derived cells in chondrogenic differentiation.

Authors:  Takaaki Koga; Takahiro Niikura; Sang Yang Lee; Yoshihiro Dogaki; Etsuko Okumachi; Kotaro Nishida; Ryosuke Kuroda; Masahiro Kurosaka
Journal:  Int Orthop       Date:  2013-03-01       Impact factor: 3.075

10.  Role of Curcuminoids and Tricalcium Phosphate Ceramic in Rat Spinal Fusion.

Authors:  Daniel A Ryan; Jiongjia Cheng; Koichi Masuda; John R Cashman
Journal:  Tissue Eng Part C Methods       Date:  2020-11-13       Impact factor: 3.056

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.